- Supported exchanges /
- NASDAQ /
- BCAX.NASDAQ
Bicara Therapeutics Inc. Common Stock (BCAX NASDAQ) stock market data APIs
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-b) for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.
Bicara Therapeutics Inc. Common Stock Financial Data Overview
19.2 | |
19.92 | |
- | |
20.5 | |
18.76 | |
17.41-28.09 | |
1 097 M | |
54 386 K | |
0 | |
-0.3213 | |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Bicara Therapeutics Inc. Common Stock Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA -58 299 000
- Earnings Per Share -3.75
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Bicara Therapeutics Inc. Common Stock Earnings via APIs
- Latest Release 2024-11-12
- EPS/Forecast NaN
Get Bicara Therapeutics Inc. Common Stock End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: